Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany 600x60px
Document › Details

Analytik Jena AG. (4/11/14). "Press Release: Analytik Jena AG Planning Merger by Absorption of CyBio AG". Jena.

Organisations Organisation Analytik Jena AG
  Group Endress+Hauser (Group)
  Organisation 2 CyBio AG
  Today Analytik Jena AG
  Group Endress+Hauser (Group)
Products Product analytical instrument
  Product 2 laboratory automation equipment
Person Person Berka, Klaus (Analytik Jena 200702 Chairman Executive Board)
     


Analytik Jena AG (Prime Standard: AJA, ISIN: DE0005213508) is planning to merge the business of its subsidiary CyBio AG, also headquartered in Jena, with its core business in the Life Science business unit. Against this backdrop, CyBio AG, a provider of modern liquid handling and laboratory automation technology for global drug discovery and the biotech industry, will be merged into Analytik Jena AG during the current financial year. A corresponding merger by absorption agreement was signed this past Friday.

As part of the merger by absorption, Analytik Jena AG plans to acquire all the remaining shares of CyBio AG by means of a method to squeeze out minority shareholders (known as a squeeze-out merger). The shareholders of CyBio AG are to draft a resolution to transfer the shares of the minority shareholders to Analytik Jena AG as the majority shareholder in return for payment of compensation in cash at the Company's General Meeting on May 22, 2014. Analytik Jena AG currently holds 91.9% of the voting rights of CyBio AG.

The business activities of the CyBio Group are to be continued after the merger becomes effective and to be expanded in the coming years. CyBio products and services will continue to be marketed as an independent CyBio product line under the CyBio brand by Analytik Jena AG. CyBio AG currently employs 98 staff members around the world and is fully consolidated in the Analytik Jena Group. Analytik Jena AG already acquired the majority of the shares of CyBio AG in 2009.

"With the strategic and operational realignment of CyBio AG, we have consistently driven business in a customer-oriented way in the areas of liquid handling and laboratory automation technology in the past five years as part of the Analytik Jena Group. CyBio AG has become an integral and successful part of the Analytik Jena AG family," said Klaus Berka, Chief Executive Officer of Analytik Jena AG. "The planned merger and structural integration is the logical continuation of this path with the aim of bundling our competencies in the Group portfolio and thus providing access for our customers to an even more comprehensive range."

   
Record changed: 2017-04-02

Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany 600x60px

More documents for Endress+Hauser (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany 600x60px




» top